← Back to Patent Explorer
US4885281A Expired / Lapsed US ⏱️ 0.0 years remaining

Sucralfate suspension

Assignee: Merck Patent GmbH
•
Filing: 1988-03-21
•
Granted: 1989-12-05
•
Expires: 2008-03-21
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The invention relates to formulations in the form of suspensions containing sucralfate, characterized in that they contain, based on the sucralfate, 1-5% by weight of xanthan gum and 1-12.5% by weight of at least one peptiser.

Inventors

  • 👤 Ullrich Hanstein
  • 👤 Lothar Bauer

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-05 16:24
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/0087; A61K9/0095; A61K31/00; A61K31/70; A61K47/00; A61K47/02; A61K47/30; A61K47/36; A61P; A61P1/00; A61P1/04

Claims Analysis

Total Claims: 6
Claim 1
Independent Claim 33 words
Pharmaceutical formulations in the form of suspensions containing sucralfate, characterised in that they contain, based on the sucralfate, 1-5% by weight of xanthan gum and 1-12.5% by weight of at least one peptiser.
Claim 2
Dependent Claim 33 words
Pharmaceutical formulations in the form of suspensions containing sucralfate, characterised in that they contain, based on the sucralfate, 1-5% by weight of xanthan gum and 1-12.5% by weight of at least one peptiser.
Claim 3
Dependent Claim 22 words
Pharmaceutical formulations according to claim 1, characterised in that the peptiser is at least one salt of phosphoric acid or citric acid.
Claim 4
Dependent Claim 23 words
Pharmaceutical formulations according to claim 1 or 2, characterised in that they contain 1-40% by weight of sucralfate, based on the total amount.
Claim 5
Dependent Claim 41 words
Method of stabilising pharmaceutical formulations in the form of suspensions containing sucralfate, characterised in that 1-5% by weight of xanthan gum and 1-12.5% by weight of at least one peptiser, based on the content of sucralfate, are added to these formulations.
Claim 6
Dependent Claim 41 words
Method of stabilising pharmaceutical formulations in the form of suspensions containing sucralfate, characterised in that 1-5% by weight of xanthan gum and 1-12.5% by weight of at least one peptiser, based on the content of sucralfate, are added to these formulations.

References Cited (Backward Citations)

EP0055313A1 Cited
EP0107209A1 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1992-12-04 1993-06-05 1993-12-05 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1996-12-04 1997-06-05 1997-12-05 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2000-12-04 2001-06-05 2001-12-05 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag